KalVista Pharmaceuticals
KALV
KALV
75 hedge funds and large institutions have $328M invested in KalVista Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
18% less capital invested
Capital invested by funds: $398M → $328M (-$70.4M)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
75
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$14.8M | |
| 2 | +$13.3M | |
| 3 | +$12.6M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$10.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.35M |
Top Sellers
| 1 | -$41.2M | |
| 2 | -$7.37M | |
| 3 | -$4.58M | |
| 4 |
VMI
VHCP Management II
New York
|
-$4.35M |
| 5 |
O
OrbiMed
New York
|
-$2.59M |